2
3
4
5
6
7 LONG TITLE
8 General Description:
9 This bill adds gabapentin to the list of controlled substances.
10 Highlighted Provisions:
11 This bill:
12 ▸ adds gabapentin to Schedule V of the list of controlled substances; and
13 ▸ makes technical and conforming changes.
14 Money Appropriated in this Bill:
15 None
16 Other Special Clauses:
17 None
18 Utah Code Sections Affected:
19 AMENDS:
20 58-37-4, as last amended by Laws of Utah 2022, Chapter 165
21
22 Be it enacted by the Legislature of the state of Utah:
23 Section 1. Section 58-37-4 is amended to read:
24 58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings
25 required -- Specific substances included in schedules.
26 (1) There are established five schedules of controlled substances known as Schedules I,
27 II, III, IV, and V which consist of substances listed in this section.
28 (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by
29 the official name, common or usual name, chemical name, or brand name designated:
30 (a) Schedule I:
31 (i) Unless specifically excepted or unless listed in another schedule, any of the
32 following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
33 ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
34 chemical designation:
35 (A) Acetyl-alpha-methylfentanyl
36 (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
37 (B) Acetyl fentanyl: (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
38 (C) Acetylmethadol;
39 (D) Acryl fentanyl (N-(1-Phenethylpiperidin-4-yl)-N-phenylacrylamide);
40 (E) Allylprodine;
41 (F) Alphacetylmethadol, except levo-alphacetylmethadol also known as
42 levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
43 (G) Alphameprodine;
44 (H) Alphamethadol;
45 (I) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
46 propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
47 (J) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
48 piperidinyl]-N-phenylpropanamide);
49 (K) Benzylpiperazine;
50 (L) Benzethidine;
51 (M) Betacetylmethadol;
52 (N) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
53 piperidinyl]-N-phenylpropanamide);
54 (O) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
55 phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
56 (P) Betameprodine;
57 (Q) Betamethadol;
58 (R) Betaprodine;
59 (S) Butyryl fentanyl (N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylbutyramide);
60 (T) Clonitazene;
61 (U) Cyclopropyl fentanyl
62 (N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);
63 (V) Dextromoramide;
64 (W) Diampromide;
65 (X) Diethylthiambutene;
66 (Y) Difenoxin;
67 (Z) Dimenoxadol;
68 (AA) Dimepheptanol;
69 (BB) Dimethylthiambutene;
70 (CC) Dioxaphetyl butyrate;
71 (DD) Dipipanone;
72 (EE) Ethylmethylthiambutene;
73 (FF) Etizolam
74 (1-Methyl-6-o-chlorophenyl-8-ethyl-4H-s-triazolo[3,4-c]thieno[2,3-e]1,4-diazepine);
75 (GG) Etonitazene;
76 (HH) Etoxeridine;
77 (II) Furanyl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]
78 furan-2-carboxamide);
79 (JJ) Furethidine;
80 (KK) Hydroxypethidine;
81 (LL) Ketobemidone;
82 (MM) Levomoramide;
83 (NN) Levophenacylmorphan;
84 (OO) Methoxyacetyl fentanyl
85 (2-Methoxy-N-(1-phenylethylpiperidinyl-4-yl)-N-acetamide);
86 (PP) Morpheridine;
87 (QQ) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
88 (RR) Noracymethadol;
89 (SS) Norlevorphanol;
90 (TT) Normethadone;
91 (UU) Norpipanone;
92 (VV) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
93 propanamide);
94 (WW) Para-fluoroisobutyryl fentanyl
95 (N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
96 (XX) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
97 (YY) Phenadoxone;
98 (ZZ) Phenampromide;
99 (AAA) Phenomorphan;
100 (BBB) Phenoperidine;
101 (CCC) Piritramide;
102 (DDD) Proheptazine;
103 (EEE) Properidine;
104 (FFF) Propiram;
105 (GGG) Racemoramide;
106 (HHH) Tetrahydrofuran fentanyl
107 (N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);
108 (III) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
109 (JJJ) Tilidine;
110 (KKK) Trimeperidine;
111 (LLL) 3-methylfentanyl, including the optical and geometric isomers
112 (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide);
113 (MMM) 3-methylthiofentanyl
114 (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
115 (NNN) 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide also
116 known as U-47700; and
117 (OOO) 4-cyano CUMYL-BUTINACA.
118 (ii) Unless specifically excepted or unless listed in another schedule, any of the
119 following opium derivatives, their salts, isomers, and salts of isomers when the existence of the
120 salts, isomers, and salts of isomers is possible within the specific chemical designation:
121 (A) Acetorphine;
122 (B) Acetyldihydrocodeine;
123 (C) Benzylmorphine;
124 (D) Codeine methylbromide;
125 (E) Codeine-N-Oxide;
126 (F) Cyprenorphine;
127 (G) Desomorphine;
128 (H) Dihydromorphine;
129 (I) Drotebanol;
130 (J) Etorphine (except hydrochloride salt);
131 (K) Heroin;
132 (L) Hydromorphinol;
133 (M) Methyldesorphine;
134 (N) Methylhydromorphine;
135 (O) Morphine methylbromide;
136 (P) Morphine methylsulfonate;
137 (Q) Morphine-N-Oxide;
138 (R) Myrophine;
139 (S) Nicocodeine;
140 (T) Nicomorphine;
141 (U) Normorphine;
142 (V) Pholcodine; and
143 (W) Thebacon.
144 (iii) Unless specifically excepted or unless listed in another schedule, any material,
145 compound, mixture, or preparation which contains any quantity of the following hallucinogenic
146 substances, or which contains any of their salts, isomers, and salts of isomers when the
147 existence of the salts, isomers, and salts of isomers is possible within the specific chemical
148 designation; as used in this Subsection (2)(a)(iii) only, "isomer" includes the optical, position,
149 and geometric isomers:
150 (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
151 α-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET;
152 (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
153 4-bromo-2,5-dimethoxy-α-methylphenethylamine; 4-bromo-2,5-DMA;
154 (C) 4-bromo-2,5-dimethoxyphenethylamine, some trade or other names:
155 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
156 (D) 2,5-dimethoxyamphetamine, some trade or other names:
157 2,5-dimethoxy-α-methylphenethylamine; 2,5-DMA;
158 (E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
159 (F) 4-methoxyamphetamine, some trade or other names:
160 4-methoxy-α-methylphenethylamine; paramethoxyamphetamine, PMA;
161 (G) 5-methoxy-3,4-methylenedioxyamphetamine;
162 (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
163 4-methyl-2,5-dimethoxy-α-methylphenethylamine; "DOM"; and "STP";
164 (I) 3,4-methylenedioxy amphetamine;
165 (J) 3,4-methylenedioxymethamphetamine (MDMA);
166 (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
167 alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
168 (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
169 N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
170 (M) 3,4,5-trimethoxy amphetamine;
171 (N) Bufotenine, some trade and other names:
172 3-(β-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
173 N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
174 (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
175 (P) Dimethyltryptamine, some trade or other names: DMT;
176 (Q) Ibogaine, some trade and other names:
177 7-Ethyl-6,6β,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
178 [5,4-b] indole; Tabernanthe iboga;
179 (R) Lysergic acid diethylamide;
180 (S) Marijuana;
181 (T) Mescaline;
182 (U) Parahexyl, some trade or other names:
183 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
184 (V) Peyote, meaning all parts of the plant presently classified botanically as
185 Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from
186 any part of such plant, and every compound, manufacture, salts, derivative, mixture, or
187 preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
188 (W) N-ethyl-3-piperidyl benzilate;
189 (X) N-methyl-3-piperidyl benzilate;
190 (Y) Psilocybin;
191 (Z) Psilocyn;
192 (AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis
193 (cannabis plant), except for marijuana as defined in Subsection 58-37-2(1)(aa)(i)(E), as well as
194 synthetic equivalents of the substances contained in the cannabis plant, or in the resinous
195 extractives of Cannabis, sp. and/or synthetic substances, derivatives, and their isomers with
196 similar chemical structure and pharmacological activity to those substances contained in the
197 plant, such as the following: Δ1 cis or trans tetrahydrocannabinol, and their optical isomers Δ6
198 cis or trans tetrahydrocannabinol, and their optical isomers Δ3,4 cis or trans
199 tetrahydrocannabinol, and its optical isomers, and since nomenclature of these substances is not
200 internationally standardized, compounds of these structures, regardless of numerical
201 designation of atomic positions covered;
202 (BB) Ethylamine analog of phencyclidine, some trade or other names:
203 N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
204 N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
205 (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
206 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
207 (DD) Thiophene analog of phencyclidine, some trade or other names:
208 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
209 (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
210 (iv) Unless specifically excepted or unless listed in another schedule, any material
211 compound, mixture, or preparation which contains any quantity of the following substances
212 having a depressant effect on the central nervous system, including its salts, isomers, and salts
213 of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
214 specific chemical designation:
215 (A) Mecloqualone; and
216 (B) Methaqualone.
217 (v) Any material, compound, mixture, or preparation containing any quantity of the
218 following substances having a stimulant effect on the central nervous system, including their
219 salts, isomers, and salts of isomers:
220 (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
221 4,5-dihydro-5-phenyl-2-oxazolamine;
222 (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
223 alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
224 (C) Fenethylline;
225 (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
226 alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
227 alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
228 methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
229 optical isomers;
230 (E) (±)cis-4-methylaminorex ((±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
231 (F) N-ethylamphetamine; and
232 (G) N,N-dimethylamphetamine, also known as
233 N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
234 (vi) Any material, compound, mixture, or preparation which contains any quantity of
235 the following substances, including their optical isomers, salts, and salts of isomers, subject to
236 temporary emergency scheduling:
237 (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
238 (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
239 (vii) Unless specifically excepted or unless listed in another schedule, any material,
240 compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate
241 (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.
242 (b) Schedule II:
243 (i) Unless specifically excepted or unless listed in another schedule, any of the
244 following substances whether produced directly or indirectly by extraction from substances of
245 vegetable origin, or independently by means of chemical synthesis, or by a combination of
246 extraction and chemical synthesis:
247 (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
248 opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
249 and their respective salts, but including:
250 (I) Raw opium;
251 (II) Opium extracts;
252 (III) Opium fluid;
253 (IV) Powdered opium;
254 (V) Granulated opium;
255 (VI) Tincture of opium;
256 (VII) Codeine;
257 (VIII) Ethylmorphine;
258 (IX) Etorphine hydrochloride;
259 (X) Hydrocodone;
260 (XI) Hydromorphone;
261 (XII) Metopon;
262 (XIII) Morphine;
263 (XIV) Oxycodone;
264 (XV) Oxymorphone; and
265 (XVI) Thebaine;
266 (B) Any salt, compound, derivative, or preparation which is chemically equivalent or
267 identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
268 substances may not include the isoquinoline alkaloids of opium;
269 (C) Opium poppy and poppy straw;
270 (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and
271 any salt, compound, derivative, or preparation which is chemically equivalent or identical with
272 any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,
273 and salts of isomers and derivatives, whether derived from the coca plant or synthetically
274 produced, except the substances may not include decocainized coca leaves or extraction of coca
275 leaves, which extractions do not contain cocaine or ecgonine; and
276 (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
277 liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
278 (ii) Unless specifically excepted or unless listed in another schedule, any of the
279 following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
280 ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
281 chemical designation, except dextrorphan and levopropoxyphene:
282 (A) Alfentanil;
283 (B) Alphaprodine;
284 (C) Anileridine;
285 (D) Bezitramide;
286 (E) Bulk dextropropoxyphene (nondosage forms);
287 (F) Carfentanil;
288 (G) Dihydrocodeine;
289 (H) Diphenoxylate;
290 (I) Fentanyl;
291 (J) Isomethadone;
292 (K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
293 levomethadyl acetate, or LAAM;
294 (L) Levomethorphan;
295 (M) Levorphanol;
296 (N) Metazocine;
297 (O) Methadone;
298 (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
299 (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
300 acid;
301 (R) Pethidine (meperidine);
302 (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
303 (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
304 (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
305 (V) Phenazocine;
306 (W) Piminodine;
307 (X) Racemethorphan;
308 (Y) Racemorphan;
309 (Z) Remifentanil; and
310 (AA) Sufentanil.
311 (iii) Unless specifically excepted or unless listed in another schedule, any material,
312 compound, mixture, or preparation which contains any quantity of the following substances
313 having a stimulant effect on the central nervous system:
314 (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
315 (B) Methamphetamine, its salts, isomers, and salts of its isomers;
316 (C) Phenmetrazine and its salts; and
317 (D) Methylphenidate.
318 (iv) Unless specifically excepted or unless listed in another schedule, any material,
319 compound, mixture, or preparation which contains any quantity of the following substances
320 having a depressant effect on the central nervous system, including its salts, isomers, and salts
321 of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
322 specific chemical designation:
323 (A) Amobarbital;
324 (B) Glutethimide;
325 (C) Pentobarbital;
326 (D) Phencyclidine;
327 (E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
328 1-piperidinocyclohexanecarbonitrile (PCC); and
329 (F) Secobarbital.
330 (v) (A) Unless specifically excepted or unless listed in another schedule, any material,
331 compound, mixture, or preparation which contains any quantity of Phenylacetone.
332 (B) Some of these substances may be known by trade or other names:
333 phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.
334 (vi) Nabilone, another name for nabilone:
335 (±)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
336 6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
337 (vii) A drug product or preparation that contains any component of marijuana,
338 including tetrahydrocannabinol, and is approved by the United States Food and Drug
339 Administration and scheduled by the Drug Enforcement Administration in Schedule II of the
340 federal Controlled Substances Act, Title II, P.L. 91-513.
341 (c) Schedule III:
342 (i) Unless specifically excepted or unless listed in another schedule, any material,
343 compound, mixture, or preparation which contains any quantity of the following substances
344 having a stimulant effect on the central nervous system, including its salts, isomers whether
345 optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,
346 and salts of isomers is possible within the specific chemical designation:
347 (A) Those compounds, mixtures, or preparations in dosage unit form containing any
348 stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were
349 listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the
350 Code of Federal Regulations, and any other drug of the quantitive composition shown in that
351 list for those drugs or which is the same except that it contains a lesser quantity of controlled
352 substances;
353 (B) Benzphetamine;
354 (C) Chlorphentermine;
355 (D) Clortermine; and
356 (E) Phendimetrazine.
357 (ii) Unless specifically excepted or unless listed in another schedule, any material,
358 compound, mixture, or preparation which contains any quantity of the following substances
359 having a depressant effect on the central nervous system:
360 (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
361 pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients
362 which are not listed in any schedule;
363 (B) Any suppository dosage form containing amobarbital, secobarbital, or
364 pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug
365 Administration for marketing only as a suppository;
366 (C) Any substance which contains any quantity of a derivative of barbituric acid or any
367 salt of any of them;
368 (D) Chlorhexadol;
369 (E) Buprenorphine;
370 (F) Any drug product containing gamma hydroxybutyric acid, including its salts,
371 isomers, and salts of isomers, for which an application is approved under the federal Food,
372 Drug, and Cosmetic Act, Section 505;
373 (G) Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:
374 ± -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
375 (H) Lysergic acid;
376 (I) Lysergic acid amide;
377 (J) Methyprylon;
378 (K) Sulfondiethylmethane;
379 (L) Sulfonethylmethane;
380 (M) Sulfonmethane; and
381 (N) Tiletamine and zolazepam or any of their salts, some trade or other names for a
382 tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
383 2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
384 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
385 flupyrazapon.
386 (iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
387 U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
388 (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
389 (-)-delta-9-(trans)-tetrahydrocannabinol.
390 (iv) Nalorphine.
391 (v) Unless specifically excepted or unless listed in another schedule, any material,
392 compound, mixture, or preparation containing limited quantities of any of the following
393 narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
394 (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
395 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of
396 opium;
397 (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
398 milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
399 therapeutic amounts;
400 (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
401 than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline
402 alkaloid of opium;
403 (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
404 than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
405 recognized therapeutic amounts;
406 (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
407 milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
408 therapeutic amounts;
409 (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
410 than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
411 recognized therapeutic amounts;
412 (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
413 more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
414 recognized therapeutic amounts; and
415 (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
416 one or more active, non-narcotic ingredients in recognized therapeutic amounts.
417 (vi) Unless specifically excepted or unless listed in another schedule, anabolic steroids
418 including any of the following or any isomer, ester, salt, or derivative of the following that
419 promotes muscle growth:
420 (A) Boldenone;
421 (B) Chlorotestosterone (4-chlortestosterone);
422 (C) Clostebol;
423 (D) Dehydrochlormethyltestosterone;
424 (E) Dihydrotestosterone (4-dihydrotestosterone);
425 (F) Drostanolone;
426 (G) Ethylestrenol;
427 (H) Fluoxymesterone;
428 (I) Formebulone (formebolone);
429 (J) Mesterolone;
430 (K) Methandienone;
431 (L) Methandranone;
432 (M) Methandriol;
433 (N) Methandrostenolone;
434 (O) Methenolone;
435 (P) Methyltestosterone;
436 (Q) Mibolerone;
437 (R) Nandrolone;
438 (S) Norethandrolone;
439 (T) Oxandrolone;
440 (U) Oxymesterone;
441 (V) Oxymetholone;
442 (W) Stanolone;
443 (X) Stanozolol;
444 (Y) Testolactone;
445 (Z) Testosterone; and
446 (AA) Trenbolone.
447 (vii) Anabolic steroids expressly intended for administration through implants to cattle
448 or other nonhuman species, and approved by the Secretary of Health and Human Services for
449 use, may not be classified as a controlled substance.
450 (viii) A drug product or preparation that contains any component of marijuana,
451 including tetrahydrocannabinol, and is approved by the United States Food and Drug
452 Administration and scheduled by the Drug Enforcement Administration in Schedule III of the
453 federal Controlled Substances Act, Title II, P.L. 91-513.
454 (ix) Nabiximols.
455 (d) Schedule IV:
456 (i) Unless specifically excepted or unless listed in another schedule, any material,
457 compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not
458 less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
459 (ii) Unless specifically excepted or unless listed in another schedule, any material,
460 compound, mixture, or preparation which contains any quantity of the following substances,
461 including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and
462 salts of isomers is possible within the specific chemical designation:
463 (A) Alprazolam;
464 (B) Barbital;
465 (C) Bromazepam;
466 (D) Butorphanol;
467 (E) Camazepam;
468 (F) Carisoprodol;
469 (G) Chloral betaine;
470 (H) Chloral hydrate;
471 (I) Chlordiazepoxide;
472 (J) Clobazam;
473 (K) Clonazepam;
474 (L) Clorazepate;
475 (M) Clotiazepam;
476 (N) Cloxazolam;
477 (O) Delorazepam;
478 (P) Diazepam;
479 (Q) Dichloralphenazone;
480 (R) Estazolam;
481 (S) Ethchlorvynol;
482 (T) Ethinamate;
483 (U) Ethyl loflazepate;
484 (V) Fludiazepam;
485 (W) Flunitrazepam;
486 (X) Flurazepam;
487 (Y) Halazepam;
488 (Z) Haloxazolam;
489 (AA) Ketazolam;
490 (BB) Loprazolam;
491 (CC) Lorazepam;
492 (DD) Lormetazepam;
493 (EE) Mebutamate;
494 (FF) Medazepam;
495 (GG) Meprobamate;
496 (HH) Methohexital;
497 (II) Methylphenobarbital (mephobarbital);
498 (JJ) Midazolam;
499 (KK) Nimetazepam;
500 (LL) Nitrazepam;
501 (MM) Nordiazepam;
502 (NN) Oxazepam;
503 (OO) Oxazolam;
504 (PP) Paraldehyde;
505 (QQ) Pentazocine;
506 (RR) Petrichloral;
507 (SS) Phenobarbital;
508 (TT) Pinazepam;
509 (UU) Prazepam;
510 (VV) Quazepam;
511 (WW) Temazepam;
512 (XX) Tetrazepam;
513 (YY) Tramadol;
514 (ZZ) Triazolam;
515 (AAA) Zaleplon; and
516 (BBB) Zolpidem.
517 (iii) Any material, compound, mixture, or preparation of fenfluramine which contains
518 any quantity of the following substances, including its salts, isomers whether optical, position,
519 or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of
520 isomers is possible.
521 (iv) Unless specifically excepted or unless listed in another schedule, any material,
522 compound, mixture, or preparation which contains any quantity of the following substances
523 having a stimulant effect on the central nervous system, including its salts, isomers whether
524 optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,
525 isomers, and salts of isomers is possible within the specific chemical designation:
526 (A) Cathine ((+)-norpseudoephedrine);
527 (B) Diethylpropion;
528 (C) Fencamfamine;
529 (D) Fenproprex;
530 (E) Mazindol;
531 (F) Mefenorex;
532 (G) Modafinil;
533 (H) Pemoline, including organometallic complexes and chelates thereof;
534 (I) Phentermine;
535 (J) Pipradrol;
536 (K) Sibutramine; and
537 (L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
538 (v) Unless specifically excepted or unless listed in another schedule, any material,
539 compound, mixture, or preparation which contains any quantity of dextropropoxyphene
540 (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
541 (vi) A drug product or preparation that contains any component of marijuana and is
542 approved by the United States Food and Drug Administration and scheduled by the Drug
543 Enforcement Administration in Schedule IV of the federal Controlled Substances Act, Title II,
544 P.L. 91-513.
545 (e) Schedule V:
546 (i) Any compound, mixture, or preparation containing any of the following limited
547 quantities of narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid,
548 which includes one or more non-narcotic active medicinal ingredients in sufficient proportion
549 to confer upon the compound, mixture, or preparation valuable medicinal qualities other than
550 those possessed by the narcotic drug alone:
551 (A) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
552 (B) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
553 grams;
554 (C) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
555 grams;
556 (D) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
557 atropine sulfate per dosage unit;
558 (E) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
559 (F) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
560 atropine sulfate per dosage unit; and
561 (G) unless specifically exempted or excluded or unless listed in another schedule, any
562 material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant
563 effect on the central nervous system, including its salts, isomers, and salts of isomers.
564 (ii) A drug product or preparation that contains any component of marijuana, including
565 cannabidiol, and is approved by the United States Food and Drug Administration and
566 scheduled by the Drug Enforcement Administration in Schedule V of the federal Controlled
567 Substances Act, Title II, P.L. 91-513.
568 (iii) Gabapentin.
569 Section 2. Effective date.
570 This bill takes effect on May 1, 2024.